Health
In study of 30000 mild-to-moderate COVID-19 patients, antibody responses can persist for five months – EurekAlert
Researchers who studied antibody responses in 30,000 patients with mild-to-moderate COVID-19 report that the patients’ antibodies were relatively stable for at…
Researchers who studied antibody responses in 30,000 patients with mild-to-moderate COVID-19 report that the patients’ antibodies were relatively stable for at least five months. Although the results do not yet provide conclusive evidence that these levels protect from reinfection, Ania Wajnberg and colleagues say they “believe it is very likely that they will decrease the odds ratio of reinfection and may attenuate disease in the case of breakthrough infection.” As the number of daily COVID-19…
-
Noosa News19 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business24 hours agoWhere will Nvidia stock be in 1 year?
-
Business22 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
General23 hours agoAboriginal policy vacuum from Liberals, Labor as NAIDOC Week starts